{"TopicDetails": {"type": 0, "ccm2Id": 46982469, "cftId": 0, "identifier": "EU4H-2024-PJ-02-4", "title": "Call for Proposals on EU Network of Youth Cancer Survivors - CR-g-24-45", "publicationDateLong": 1718668800000, "callIdentifier": "EU4H-2024-PJ-02", "callTitle": "EU4H Action Grants 2024", "callccm2Id": 46908104, "allowPartnerSearch": true, "frameworkProgramme": {"id": 43332642, "abbreviation": "EU4H", "description": "EU4 Health Programme (EU4H)"}, "programmeDivision": [{"id": 43332657, "abbreviation": "Health", "description": "Improving and fostering health in the Union to reduce the burden of communicable and non-communicable diseases"}, {"id": 43332653, "abbreviation": "EU4H-1", "description": "EU4H-1"}], "topicMGAs": [], "sme": false, "actions": [{"status": {"id": 31094502, "abbreviation": "Open", "description": "Open"}, "types": [{"typeOfAction": "EU4H-PJG EU4H Project Grants", "typeOfMGA": [{"id": 43326018, "abbreviation": "EU4H-AG", "description": "EU4H Action Grant Budget-Based"}]}], "plannedOpeningDate": "18 June 2024", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["10 October 2024"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3543022": [{"action": "EU4H-2024-PJ-02-4 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "18 June 2024", "deadlineModel": "single-stage", "deadlineDates": ["10 October 2024"], "budgetYearMap": {"2024": 5000000}, "budgetTopicActionMap": {}}], "3543024": [{"action": "EU4H-2024-PJ-02-3 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "18 June 2024", "deadlineModel": "single-stage", "deadlineDates": ["10 October 2024"], "budgetYearMap": {"2024": 7400000}, "budgetTopicActionMap": {}}], "3543026": [{"action": "EU4H-2024-PJ-02-1 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "18 June 2024", "deadlineModel": "single-stage", "deadlineDates": ["10 October 2024"], "budgetYearMap": {"2024": 8000000}, "budgetTopicActionMap": {}}], "3543028": [{"action": "EU4H-2024-PJ-02-2 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "18 June 2024", "deadlineModel": "single-stage", "deadlineDates": ["10 October 2024"], "budgetYearMap": {"2024": 5000000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2024"]}, "description": "<SPAN class=\"topicdescriptionkind\">Objective</SPAN>:<p>This action supports the implementation of the Europe\u2019s Beating Cancer Plan to support childhood cancer and implements the EU4Health Programme\u2019s general objective to improve and foster health in the Union (Article 3, point (a), of Regulation (EU) 2021/522) through the specific objectives defined in Article 4, points (a) and (g), of Regulation (EU) 2021/522.</p><p>The overall aim of maintaining the networks is to continue the collaboration between different existing stakeholder organisations and, through this network to further support social networking and further develop user friendly digital tools to easily access the information and improve the links amongst individuals, patients, children, adolescents and young adults (CAYA) cancer survivors, carers, researchers, and social and health professionals active in cancer prevention and care across the Union and countries associated to the EU4Health Programme. In addition, a healthy lifestyle promoting network could also be integrated in the mobile application and website. Furthermore, the network will consider relapse / metastatic cancer. The network should support and provide all the necessary information related to metastatic cancer.</p><p>The network will foster social networking, peer-support, coaching, knowledge-exchange, and aims at improving:</p><p>a) the quality of life of survivors (including mental health, education and career support, follow-up care and transition);</p><p>b) the care for adolescents and young adults (AYA) with cancer (including metastatic cancer);</p><p>c) Equality, Diversity and Inclusion (EDI) along the whole treatment and survivorship trajectory;</p><p>d) promote healthy lifestyles through interaction and exchange with peers, with people with a similar disease history, with friends as well as with healthcare organisations.</p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>This action is meant to maintain and further develop the \u2018EU Network of Youth Cancer Survivors\u2019 to foster social networking, peer-support, coaching, knowledge-exchange and improve the quality of life of young cancer survivors. The action is a follow-up project to the action grants EU4H-2021-PJ-04 (EU-CAYAS-NET project and OACCUs project).</p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p>The action will:</p><p>a) improve the communication between children, adolescent, and young adult cancer survivors, formal and informal carers, and civil society;</p><p>b) strengthen the knowledge on how to make a difference in the lives of young people with cancer and survivors;</p><p>c) increase the knowledge and support for patients with relapse and metastatic cancer;</p><p>d) increase the knowledge and support for patients on how to tackle the side-effects of treatments.</p><p>e) provide resources for survivors to learn how to become an advocate to bring key messages and knowledge on cancer survivorship to main target groups (survivors, healthcare professionals, researchers, health policy makers).</p><p>f) provide resources for survivors to pursue a healthier lifestyle, notably via sport and physical activities, healthier nutrition and mental wellbeing.</p><p>The action contributes to Europe\u2019s Beating Cancer Plan flagship initiative on paediatric cancer, which specifically mentions the EU Network of Youth Cancer Survivors as being directly linked with the activities of the \u201cChildhood cancers and cancers in adolescents and young adults: cure more and cure better\u201d initiative. This initiative, supported under the Horizon Europe Cancer Mission, will directly benefit from the deliverables of this action.</p>\n", "conditions": "<p><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Conditions<br />\r\n<br type=\"_moz\" />\r\n</span></b></p>\r\n<p><b><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:&#10;text1;mso-themetint:191;mso-ansi-language:EN-US\">1.&nbsp;</span></b><b><span lang=\"EN-US\">Admissibility conditions: </span></b><span lang=\"EN-US\">described in section 5 of the call document</span>&nbsp;</p>\n<p><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\">&nbsp;described in Part B of the Application Form available in the Submission System</span></p>\n<p><b><span lang=\"EN-US\">2. Eligible countries:&nbsp;</span></b><span lang=\"EN-US\">described in section 6 of of the call document</span></p>\n<p><b><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\">&nbsp;described in section 6 of the call document</span></p>\n<p><b>4. Financial and operational capacity and exclusion:&nbsp;</b>described in&nbsp;<span lang=\"EN-US\">section 7 of the call document</span></p>\n<p><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></p>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Award criteria, scoring and thresholds:</span></b><span lang=\"EN-US\">&nbsp;described in section 9 of the call document</span></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">Submission and evaluation processes</span></b><b><span lang=\"EN-US\">:</span></b><span lang=\"EN-US\">&nbsp;described&nbsp;<span style=\"color: rgb(64, 64, 64);\">section 8 of the call document and the</span>&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Online Manual</span></a></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Indicative timeline for evaluation and grant agreement:&nbsp;</span></b><span lang=\"EN-US\">described in section 4 of the call document</span></li>\r\n</ul>\n<p><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">6</span></b><b><span lang=\"EN-US\">. Legal and financial set-up of the grants:&nbsp;</span></b><span lang=\"EN-US\">described&nbsp;<span style=\"color: rgb(64, 64, 64);\">in section 10 of the call document</span></span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Documents<br />\r\n<br />\r\n<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"><b><span lang=\"EN-US\">Call documents:</span></b></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2024/call-fiche_eu4h-2024-pj-02_en.pdf\" target=\"_blank\">Call document </a><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.4; background-color: rgb(198, 219, 239); box-sizing: inherit; font-size: 16px; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/af_eu4h_en.pdf\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\">Standard application form ([ToA])</a>&nbsp;</span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.4; background-color: rgb(198, 219, 239); box-sizing: inherit; font-size: 16px; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/detailed-budget-table_eu4h_en.xlsx\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\">Detailed budget table ([ToA])</a></span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.4; background-color: rgb(198, 219, 239); box-sizing: inherit; font-size: 16px; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span style=\"box-sizing: inherit;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/agr-contr/mga_eu4h_en.pdf\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\">EU4Health Programme General MGA v1.1</a></span></p>\r\n<p style=\"padding: 3px 0px; margin: 0px; line-height: 1.4; background-color: rgb(198, 219, 239); box-sizing: inherit; font-size: 16px; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span class=\"MsoHyperlink\" style=\"box-sizing: inherit;\"><span style=\"box-sizing: inherit;\"><a href=\"https://health.ec.europa.eu/publications/2024-eu4health-work-programme_en\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\">EU4Health Work Programme 2024</a></span></span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.4; background-color: rgb(198, 219, 239); box-sizing: inherit; font-size: 16px; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0522\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\">EU4Health&nbsp;</span></a><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0522\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\">Regulation 2021/522</a></span></span><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><br style=\"box-sizing: inherit;\" />\r\n</span><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; cursor: pointer !important;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\">EU Financial Regulation 2018/1046</span></a></p>\n", "supportInfo": "<p><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">For help related to this</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><b style=\"font-family: Arial, sans-serif; font-size: 9pt;\">call</b><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">, please contact:</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><a href=\"mailto:HaDEA-HP-CALLS@ec.europa.eu\" target=\"_blank\" style=\"color: rgb(40, 151, 183); font-family: Arial, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">HaDEA-HP-CALLS@ec.europa.eu</a></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;grantAndTendertype=1;categories=p_submission_eval;programme=null;actions=;keyword=;period=null\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Funding &amp; Tenders Portal FAQ</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Submission of proposals.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">IT Helpdesk</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Contact the IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Online Manual</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Step-by-step online guide through the Portal processes from proposal preparation and submission to reporting on your on-going project. Valid for all 2021-2027 programmes.</span></p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [{"callIdentifier": "EU4H-2024-PJ-02", "status": "Open", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "EU4H-PJG", "criterionDescription": "EU4H Project Grants", "url": "https://ec.europa.eu/research/participants/submission/manage/screen/submission/create-draft/37342?topic=EU4H-2024-PJ-02-4", "startDate": "Jun 18, 2024 12:00:00 AM", "endDate": "Oct 10, 2024 5:00:00 PM", "mgaDescription": "EU4H Action Grant Budget-Based", "mgaCode": "EU4H-AG"}], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"additionalInfo": "<p>&nbsp;<span style=\"text-align: justify; font-size: 10pt; font-family: Verdana, sans-serif;\">On 24 March 2021, the EU4Health Regulation was adopted as part of the EU Multiannual Financial Framework for the 2021-2027 period. The EU4Health Regulation established 'the EU4Health Programme'. This marks an important step towards making available instruments and solutions to support Member States in building stronger, more resilient and accessible health systems.&nbsp;</span><span lang=\"EN-GB\" style=\"text-align: justify; font-size: 10pt; font-family: Verdana, sans-serif;\">&nbsp;</span></p>\r\n<p class=\"paragraph\" style=\"margin:0cm;text-align:justify;vertical-align:baseline\"><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-fareast-language:EN-GB\">The EU4Health Programme represents an unprecedented level of financial commitment for the EU in health in comparison with previous health programmes. The Programme is EU's response to the current public health emergency that will make a significant contribution to the post-COVID-19 recovery aiming to:</span><span lang=\"EN-GB\" style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB\">&nbsp;<o:p></o:p></span></p>\r\n<p class=\"paragraph\" style=\"margin:0cm;text-align:justify;vertical-align:baseline\"><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-fareast-language:EN-GB\">- improve public health in the Union through disease prevention and health promotion, as well as international health initiatives and cooperation;</span><span lang=\"EN-GB\" style=\"font-size:&#10;10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:Verdana;&#10;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB\">&nbsp;<o:p></o:p></span></p>\r\n<p class=\"paragraph\" style=\"margin:0cm;text-align:justify;vertical-align:baseline\"><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-fareast-language:EN-GB\">- protect people from serious cross-border health threats through prevention, preparedness and response to cross-border health threats; complementing national stockpiling of essential crisis-relevant products; and establishing a reserve of medical, healthcare and support staff;</span><span lang=\"EN-GB\" style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB\">&nbsp;<o:p></o:p></span></p>\r\n<p class=\"paragraph\" style=\"margin:0cm;text-align:justify;vertical-align:baseline\"><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-fareast-language:EN-GB\">- improve access to medicinal products, medical devices and crisis-relevant products by encouraging sustainable production and supply chains and innovation in the Union and efficient use of medicinal products;</span><span lang=\"EN-GB\" style=\"font-size:&#10;10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:Verdana;&#10;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB\">&nbsp;<o:p></o:p></span></p>\r\n<p class=\"paragraph\" style=\"margin:0cm;text-align:justify;vertical-align:baseline\"><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-fareast-language:EN-GB\">- strengthen the national health systems through improved health data use and re-use, development of digital tools and services, digital transformation of healthcare; enhancing access to healthcare; developing and implementing EU health legislation and evidence-based decision making; and integrated work among Member States' health systems.</span><span lang=\"EN-GB\" style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;&#10;mso-bidi-font-family:Verdana;color:black;mso-ansi-language:EN-GB;mso-fareast-language:&#10;EN-GB\"><o:p></o:p></span></p>", "latestInfos": [{"approvalDate": "Jun 18, 2024 12:00:01 AM", "lastChangeDate": "Jun 18, 2024 12:00:01 AM", "content": "The submission session is now available for: EU4H-2024-PJ-02-1(EU4H-PJG), EU4H-2024-PJ-02-3(EU4H-PJG), EU4H-2024-PJ-02-2(EU4H-PJG), EU4H-2024-PJ-02-4(EU4H-PJG)"}], "hasForthcomingTopics": false, "hasOpenTopics": true, "allClosedTopics": false}}}